Abcam
Abcam61About
What does Abcam do?
Abcam provides life science research tools, including antibodies, proteins, kits, and reagents. They offer innovative solutions like SimpleStep™ ELISA kits and MollAI for intelligent product recommendations, serving researchers worldwide to accelerate scientific progress. Their products are highly cited and validated, with a focus on recombinant antibodies and specialized tools for areas like spatial biology and Alzheimer's research.
What is Abcam's revenue?
StartupHub estimates Abcam's annual revenue at $27.8M (range $9.2M to $95.9M, 34% confidence), based on comparable companies in the sector.
What is Abcam's valuation?
StartupHub estimates Abcam's effective valuation at $15.2B (range $5.1B to $22.5B, 42% confidence), based on comparable companies in the sector.
How much funding has Abcam raised?
Abcam has raised a total of $257M in funding. The most recent round on record is Series D.
Where is Abcam headquartered?
Abcam is headquartered in Cambridge, United Kingdom.
When was Abcam founded?
Abcam was founded in 1998.
What industry does Abcam operate in?
Abcam operates in Biotechnology, Life Sciences, Discovery Tools, Antibodies, Reagents, Assays.
No comments yet. Be the first to share your take.